TipRanks
Perspective Therapeutics (CATX)
:CATX
US Market
CATX
Perspective Therapeutics
RESEARCH TOOLSreports
Want to see CATX full AI Analyst Report?

Perspective Therapeutics (CATX) Income Statement

1,669 Followers

Perspective Therapeutics Income Statement

Last quarter (Q2 2026), Perspective Therapeutics's total revenue was $81.00K, a decrease of -72.07% from the same quarter last year. In Q2, Perspective Therapeutics's net income was $-26.79M. See Perspective Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Jun 22Jun 21
Total Revenue
$ 0.00$ 1.45M$ 1.43M$ 5.42M$ 10.79M
Gross Profit
$ 0.00$ -852.00K$ 1.43M$ 2.37M$ 4.62M
Operating Expenses
$ 113.56M$ 65.94M$ 42.38M$ 11.47M$ 12.01M
Depreciation and Amortization
$ 3.25M$ 2.31M$ 981.00K$ 320.00K$ 248.00K
EBITDA
$ -100.80M$ -64.49M$ -39.96M$ -8.48M$ -7.14M
Operating Income
$ -113.56M$ -66.80M$ -40.94M$ -9.10M$ -7.39M
Other Income/Expenses
$ 9.14M$ -13.63M$ 835.00K$ 618.00K$ 119.00K
Pretax Income
$ -104.43M$ -80.43M$ -40.11M$ -8.48M$ -7.27M
Net Income
$ -103.12M$ -79.28M$ -46.51M$ -10.76M$ -7.27M
Per Share Metrics
Basic EPS
$ -1.40$ -1.23$ -0.85$ -0.60$ -0.50
Diluted EPS
$ -1.40$ -1.23$ -0.85$ -0.60$ -0.50
Weighted Average Shares Outstanding
 73.81M 64.42M 54.91M 18.02M 14.20M
Weighted Average Shares Outstanding (Diluted)
 73.81M 64.42M 54.91M 14.21M 14.20M
Currency in USD

Perspective Therapeutics Earnings and Revenue History